Lucinactant clinical trials
Also written SURFAXIN®.
How each study uses lucinactant is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- 6 Mar 2012 · SURFAXIN · NDA 021746 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
4 studies that test it; most in 2000 (1)
| Year | Studies |
|---|---|
| 2000 | 1 |
| 2005 | 1 |
| 2007 | 1 |
| 2021 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 4 · Other 0
Windtree Therapeutics (4)
Studies
Open first, then newest update. How each study uses lucinactant is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- The Safety and Preliminary Tolerability of Lyophilized Lucinactant in Adults With Coronavirus Disease 2019 (COVID-19)CompletedPhase 2Windtree TherapeuticsNCT04389671Written as Lucinactant
- SURFAXIN® Treatment for Prevention of Bronchopulmonary Dysplasia (BPD) in Very Low Birth Weight (VLBW) Infants.TerminatedPhase 2Windtree TherapeuticsNCT00215540Written as Lucinactant 175 mg/kg
- Lucinactant for Treatment of Acute Hypoxemic Respiratory Failure in Children up to Two Years OldCompletedPhase 2Windtree TherapeuticsNCT00578734Written as Lucinactant
- Phase III Randomized Study of Lucinactant in Full Term Newborn Infants With Meconium Aspiration SyndromeTerminatedPhase 3Windtree TherapeuticsNCT00004500Written as Lucinactant
Codes
What other systems call lucinactant · ClinicalTrials.gg INT004801
- UNII (FDA) 5BSH2G9BH8LUCINACTANTOne source FDA
- RxNorm 1293254One source FDA
- NCI Thesaurus C172611LucinactantOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 5BSH2G9BH8 | LUCINACTANT | One source FDA |
| RxNorm | 1293254 | — | One source FDA |
| NCI Thesaurus | C172611 | Lucinactant | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.